News

Chronic lymphocytic leukaemia CLL explained Can patients live normally An oncologist reveals how modern treatments help ...
Patients with chronic lymphocytic leukemia (CLL) who experience Richter transformation have a poor prognosis, but ibrutinib ...
A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL).
Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced cases of certain blood cancers. Takeda holds an exclusive option to ...
Do CLL Alternative Therapies Work? Targeted drugs, surgery, and radiation are common treatments for chronic lymphocytic leukemia (CLL), but complementary therapy can also play a role in helping ...
It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and ...
New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...
As a way to grieve, Meaghan started writing, those thoughts and feelings turned into a book called ‘Widows Can Love Again’.
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia ... in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...
UBS lowered the firm’s price target on Nurix Therapeutics (NRIX) to $30 from $35 and keeps a Buy rating on the shares. Lead program ...
Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders ...